Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
5-hydroxyindoleacetic Acid (5-HIAA)
5%
Advanced Parkinson's Disease
5%
Anti-Parkinson
5%
Cerebral Microdialysis
5%
Corpus Striatum
5%
DOPAC
29%
Dopamine
17%
Dopamine D3 Receptor
5%
Dopamine Level
11%
Dopamine Metabolism
100%
Dopamine Metabolites
5%
Dopamine Receptor
5%
Dopamine Receptor Supersensitivity
5%
Dopamine Release
5%
Dopaminergic Pathway
5%
Electroconvulsive Shock
100%
Extracellular Concentrations
5%
L-DOPA
100%
L-dopamine
100%
Microdialysis
5%
Nigrostriatal Dopamine
5%
Parkinson's Disease Model
5%
Receptor Sensitivity
5%
Repeated Administration
5%
Sham
11%
Shock Therapy
5%
Shock-induced
5%
Striatal
100%
Striatal Dopamine
5%
Treatment Course
5%
Neuroscience
Dopamine
100%
Dopamine Receptor
11%
Dopamine Release
5%
Electric Shock
100%
In Vivo
100%
L-DOPA
100%
Metabolic Pathway
100%
Microdialysis
5%
Parkinson's Disease
11%
Striatum
5%
Pharmacology, Toxicology and Pharmaceutical Science
3,4 Dihydroxyphenylacetic Acid
29%
Antiparkinson Agent
5%
DOPA
100%
Dopamine
100%
Dopamine Receptor
11%
Electric Shock
100%
Microdialysis
5%
Parkinson's Disease
11%
Rat
11%